Award recognizes MMC’s outstanding respiratory products and services, and commitment to excellence.

 PLATTSBURGH, NY (November 12, 2019)—Monaghan Medical Corporation (MMC) has received the prestigious American Association of Respiratory Care (AARC) Zenith Award for the fifth consecutive year. The award was …

Anatomically designed mask will assist millions of Americans suffering from chronic lung disease

PLATTSBURGH, NY (June 5, 2019) – Monaghan Medical Corporation (MMC) today introduced new product enhancements to continue their mission to ensure device quality for patients. Close to …

Two new publications build on previous evidence that not all devices are equally effective in delivering asthma control.

PLATTSBURGH, N.Y., Jan. 31, 2018 — A recent article in Pulmonary Pharmacology and Physiology¹ provides in vitro evidence that the AEROCHAMBER …

Post-operative pulmonary complications (PPCs) are a major burden to the healthcare system.  A new real-world study published in Pulmonary Therapy, indicates significant reductions in costs when using the AEROBIKA® oscillating positive expiratory pressure (OPEP) device in the postoperative care setting.1 …

SYRACUSE, NY, 21 February, 2017 – Monaghan Medical Corporation (MMC) today announced the publication of a study in Pulmonary Therapy showing treatment with the Aerobika^® device can significantly reduce the recurrence of exacerbations of COPD in the crucial 30-day …

SYRACUSE, NY, January 12, 2017 – Monaghan Medical Corporation (MMC) today announced that the findings of a study published in the most recent issue of Academic Radiology shows that patients with non-cystic fibrosis (CF) bronchiectasis responded favorably to airway maintenance …

Real-world study presented at CHEST 2016 Annual Meeting in Los Angeles

SYRACUSE, NY, October 27, 2016 – Monaghan Medical Corporation (MMC) today announced that a new study presented to the American College of Chest Physicians (CHEST) shows MMC’s Aerobika® device …